McKesson Co. (NYSE:MCK) Shares Acquired by Voya Financial Advisors Inc.

Voya Financial Advisors Inc. grew its holdings in shares of McKesson Co. (NYSE:MCK) by 9.1% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,667 shares of the company’s stock after purchasing an additional 139 shares during the period. Voya Financial Advisors Inc.’s holdings in McKesson were worth $951,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the stock. Norges Bank acquired a new position in McKesson in the 4th quarter worth approximately $1,200,361,000. Marshall Wace LLP raised its stake in McKesson by 59,720.3% during the 4th quarter. Marshall Wace LLP now owns 358,922 shares of the company’s stock valued at $204,553,000 after purchasing an additional 358,322 shares during the last quarter. Proficio Capital Partners LLC acquired a new stake in McKesson during the fourth quarter worth about $178,397,000. Alliancebernstein L.P. raised its stake in shares of McKesson by 46.6% in the fourth quarter. Alliancebernstein L.P. now owns 855,332 shares of the company’s stock valued at $487,462,000 after purchasing an additional 272,068 shares in the last quarter. Finally, Voya Investment Management LLC boosted its position in shares of McKesson by 259.7% during the 4th quarter. Voya Investment Management LLC now owns 338,378 shares of the company’s stock valued at $192,845,000 after acquiring an additional 244,315 shares in the last quarter. Institutional investors own 85.07% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on MCK. Wells Fargo & Company lifted their price target on shares of McKesson from $641.00 to $691.00 and gave the company an “equal weight” rating in a report on Friday, March 14th. Cfra Research lowered McKesson from a “moderate buy” rating to a “hold” rating in a report on Friday, April 4th. Mizuho lifted their target price on McKesson from $630.00 to $690.00 and gave the company a “neutral” rating in a research report on Thursday, April 3rd. Evercore ISI lifted their price target on McKesson from $650.00 to $675.00 and gave the stock an “outperform” rating in a report on Thursday, February 6th. Finally, Morgan Stanley lifted their target price on McKesson from $642.00 to $745.00 and gave the stock an “overweight” rating in a report on Wednesday, April 2nd. Three analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $668.50.

Insider Activity

In other news, CEO Brian S. Tyler sold 8,961 shares of the business’s stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $597.99, for a total value of $5,358,588.39. Following the completion of the sale, the chief executive officer now directly owns 60,664 shares in the company, valued at approximately $36,276,465.36. The trade was a 12.87 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Leann B. Smith sold 188 shares of McKesson stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total transaction of $114,602.92. Following the completion of the transaction, the executive vice president now directly owns 1,051 shares in the company, valued at approximately $640,679.09. The trade was a 15.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 18,110 shares of company stock worth $10,855,706. 0.11% of the stock is owned by corporate insiders.

McKesson Stock Down 0.6 %

Shares of NYSE:MCK opened at $688.26 on Friday. McKesson Co. has a twelve month low of $464.42 and a twelve month high of $728.32. The firm has a market capitalization of $86.26 billion, a price-to-earnings ratio of 31.51, a PEG ratio of 1.29 and a beta of 0.49. The stock’s 50 day moving average is $659.36 and its 200-day moving average is $605.06.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 EPS for the quarter, missing analysts’ consensus estimates of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. Equities research analysts anticipate that McKesson Co. will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd were given a $0.71 dividend. This represents a $2.84 annualized dividend and a dividend yield of 0.41%. The ex-dividend date was Monday, March 3rd. McKesson’s dividend payout ratio (DPR) is currently 13.00%.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.